e-learning
resources
Courses
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Idiopathic Pulmonary Fibrosis (IPF)
J. Behr (Munich, Germany)
Source:
ERS Course 2019 - Interstitial Lung Diseases
Number:
6
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Behr (Munich, Germany). Idiopathic Pulmonary Fibrosis (IPF). ERS Course 2019 - Interstitial Lung Diseases
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Praveen Kumar Molanguri - 28.08.2018 15:56
excellent
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
IPF - Idiopathic Pulmonary Fibrosis
Source: Breathe, 15 (2) 153; 10.1183/20734735.ELF152
Year: 2019
Idiopathic Pulmonary Fibrosis (IPF): Should it be all about the FVC?
Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments
Year: 2018
Identification of profibrotic cells in the Idiopathic Pulmonary Fibrosis (IPF) lung
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020
Management-related costs of Idiopathic Pulmonary Fibrosis (IPF) in Belgium
Source: Virtual Congress 2020 – How do different treatment strategies translate into costs
Year: 2020
Treatment of Idiopathic Pulmonary Fibrosis
Source: Guideline 2015
Year: 2015
Idiopathic pulmonary fibrosis (IPF)
Source: ERS Course 2016
Year: 2016
Platelet activation indices in patients with Idiopathic Pulmonary Fibrosis
Source: International Congress 2014 – ILDs 5
Year: 2014
Tele-rehabilitation program in Idiopathic Pulmonary Fibrosis
Source: International Congress 2019 – M-health/e-health I
Year: 2019
Evaluation of Dyspnea Questionnaires in Patients with Idiopathic Pulmonary Fibrosis (IPF).
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018
Non - IPF Idiopathic Interstitial Pneumonia (IIPs)
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2019
Non - IPF Idiopathic Interstitial Pneumonia (IIPs)
Source: ERS Courses: Interstitial Lung Diseases
Year: 2019
Non - IPF Idiopathic Interstitial Pneumonia (IIPs)
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2018
Lymphoid follicles are a prominent feature in Idiopathic Pulmonary Fibrosis (IPF) lungs.
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019
Pirfenidone in idiopathic pulmonary fibrosis - description of a German cohort
Source: International Congress 2014 – ILDs 4
Year: 2014
Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry
Source: Eur Respir J , 49 (2) 1601592; DOI: 10.1183/13993003.01592-2016
Year: 2017
Idiopathic pulmonary fibrosis is associated with a preferential alteration of kCO rather than of DLCO
Source: International Congress 2014 – ILDs 6
Year: 2014
Plasma protein signature of idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013
Idiopathic pulmonary fibrosis
Source: School Course 2014 - Interstitial lung diseases
Year: 2014
Idiopathic pulmonary fibrosis
Source: Eur Respir Monogr 2013; 62: 37-53
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept